Effect of alirocumab on coronary atheroma volume in Japanese patients with acute coronary syndromes and hypercholesterolemia not adequately controlled with statins: ODYSSEY J-IVUS rationale and design

导出原文传递

翻译打印收藏纠错

作者： Ako, Junya ^[1] ; Hibi, Kiyoshi ^[2] ; Kozuma, Ken ^[3] ; Miyauchi, Katsumi ^[4] ; Morino, Yoshihiro ^[5] ; Shinke, Toshiro ^[6] ; Tsujita, Kenichi ^[7] ; Uno, Kiyoko ^[8] ; Kawabata, Yumiko ^[9] ; Hiro, Takafumi ^[10]

作者单位： Kobe Univ, Div Cardiovasc Med, Dept Internal Med, Grad Sch Med, Kobe, Hyogo, Japan ^[1] Nihon Univ, Div Cardiol, Dept Med, Sch Med,Itabashi Ku, Tokyo, Japan ^[2] Sanofi, Cardiovasc Med, Shinjuku Ku, Tokyo, Japan ^[3] Sanofi, R&D, Clin Sci & Operat, Shinjuku Ku, Tokyo, Japan ^[4] Iwate Med Univ, Div Cardiol, Dept Internal Med, Morioka, Iwate, Japan ^[5] Yokohama City Univ, Med Ctr, Div Cardiol, Yokohama, Kanagawa, Japan ^[6] Teikyo Univ Hosp, Div Cardiol, Itabashi Ku, Tokyo, Japan ^[7] Juntendo Univ Hosp, Div Cardiovasc Med, Dept Internal Med, Bunkyo Ku, Tokyo, Japan ^[8] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Kumamoto, Japan ^[9] Kitasato Univ Hosp, Dept Cardiovasc Med, Sagamihara, Kanagawa, Japan ^[10]

关键词 Alirocumab Low-density lipoprotein cholesterol Coronary artery disease Monoclonal antibody

发布时间 2019-03-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交